The insulin receptor negatively regulates the action of Pseudomonas toxin-based immunotoxins and native Pseudomonas

Xiu Fen Liu1, David J FitzGerald, Ira Pastan

  • 1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Cancer Research
|January 26, 2013
PubMed

Insights

Lowering insulin receptor levels boosts the effectiveness of SS1P immunotoxin against cancers like mesothelioma. This occurs because reduced insulin receptor levels enhance SS1P

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • SS1P is an antimesothelin immunotoxin targeting mesothelin-expressing tumors.
  • Mesothelin is found in mesothelioma, ovarian, lung, and pancreatic cancers.
  • Insulin receptor signaling is a known survival factor for cancer cells.

Purpose of the Study:

  • To investigate the effect of reducing insulin receptor levels on SS1P immunotoxin efficacy.
  • To determine the mechanism by which insulin receptor levels influence SS1P's cytotoxic action.

Main Methods:

  • Utilized siRNA to knock down insulin receptor expression in human cancer cell lines.
  • Assessed the cytotoxicity of SS1P and other agents (Pseudomonas exotoxin A, TRAIL, etoposide, cycloheximide) after insulin receptor knockdown.
  • Analyzed SS1P cleavage by furin and its subsequent effect on elongation factor 2.

Main Results:

  • siRNA-mediated insulin receptor knockdown significantly enhanced SS1P toxicity in multiple cell lines.
  • Knockdown also increased the cytotoxicity of native Pseudomonas exotoxin A.
  • The enhancement was specific to SS1P and Pseudomonas exotoxin A, not affecting responses to TRAIL, etoposide, or cycloheximide.
  • Insulin receptor knockdown increased SS1P cleavage by furin, leading to greater elongation factor 2 inactivation.

Conclusions:

  • The insulin receptor negatively regulates the cytotoxic action of SS1P immunotoxin.
  • Targeting the insulin receptor may represent a strategy to improve SS1P efficacy in treating mesothelin-expressing cancers.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...